clinical trials

Harnessing Social Media for Clinical Trial Recruitment
BioSpace
Tue, 11/14/23 - 10:59 am
clinical trials
clinical trial recruitment
social media
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
BioSpace
Tue, 11/14/23 - 10:55 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Bayer to withdraw follicular lymphoma therapy after trial failure
Clinical Trials Arena
Tue, 11/14/23 - 09:37 am
Bayer
Aliqopa
relapsed follicular lymphoma
clinical trials
Viatris and Theravance report data from COPD treatment trial
Clinical Trials Arena
Tue, 11/14/23 - 09:24 am
Viatris
Theravance
clinical trials
Yupelri
COPD
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
Aclaris shares plummet on terminating development of rheumatoid arthritis drug
Reuters
Mon, 11/13/23 - 10:00 am
Aclaris
Therapeutics
rheumatoid arthritis
clinical trials
zunsemetinib
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Vaccitech reemerges as Barinthus with hep B data showing declines in infection levels
Fierce Biotech
Fri, 11/10/23 - 12:05 pm
Barinthus Biotherapeutics
Vaccitech
clinical trials
hepatitis B
Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry
BioSpace
Fri, 11/10/23 - 10:14 am
Neurocrine
neuropsychiatric
clinical trials
focal onset seizures
major depressive disorder
NBI-921352
NBI-1065846
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
Clinical Trials Arena
Fri, 11/10/23 - 10:06 am
AstraZeneca
clinical trials
Imfinzi
hepatocellular carcinoma
Novartis’ urticaria drug meets all endpoints in Phase III trials
Clinical Trials Arena
Fri, 11/10/23 - 10:05 am
Novartis
remibrutinib
chronic spontaneous urticaria
clinical trials
Janssen’s antibody drug shows phase 2 potential in rheumatoid arthritis
Biopharma Reporter
Thu, 11/9/23 - 09:55 am
Janssen
JNJ
rheumatoid arthritis
nipocalimab
clinical trials
Health equity and trial diversity questions still not answered by pharma
Clinical Trials Arena
Thu, 11/9/23 - 09:46 am
clinical trials
clinical trial diversity
Lumos stock jumps as phase 2 results bring first oral growth hormone drug closer to market
Fierce Biotech
Wed, 11/8/23 - 11:59 am
Lumos Pharma
clinical trials
pediatric growth hormone deficiency
LUM-201
Durect fails alcohol-associated hepatitis trial, plans phase 3 anyway as investors scorch stock
Fierce Biotech
Wed, 11/8/23 - 11:33 am
Durect
alcohol-associated hepatitis
hepatitis
clinical trials
Amgen reports data from Sjögren’s Syndrome treatment trial
Clinical Trials Arena
Wed, 11/8/23 - 10:18 am
Amgen
clinical trials
dazodalibep
Sjögren’s syndrome
Even with phase 2 success, Ventyx halts TYK2 inhibitor, sending stock plummeting 70%
Fierce Biotech
Tue, 11/7/23 - 10:00 am
Ventyx Biosciences
clinical trials
TYK2 inhibitors
VTX958
psoriasis
Gilead Sciences and Arcus Biosciences report cancer trial data
Clinical Trials Arena
Tue, 11/7/23 - 09:46 am
Gilead Sciences
Arcus Biosciences
domvanalimab
zimberelimab
upper GI cancers
clinical trials
Celldex laces up next to Big Pharma players as drug reduces severity of chronic hives
Fierce Biotech
Mon, 11/6/23 - 11:31 am
Celldex Therapeutics
clinical trials
monoclonal antibodies
barzolvolimab
chronic hives
MoonLake hopes another phase 2 win helps IL-17 drug shine brighter in inflammatory race
Fierce Biotech
Mon, 11/6/23 - 11:29 am
MoonLake
IL-17 inhibitors
clinical trials

Pages